Spectral AI, Inc., a company specializing in AI-based predictive medical diagnostic tools, has released its annual 10-K report, detailing significant financial and operational achievements over the past year. The report highlights the company’s improved financial performance, strategic initiatives, and the challenges it faces in the evolving cybersecurity landscape.
Financial Highlights
- Research and development revenue: $29.581 million, reflecting an increase from the previous year’s $18.056 million, primarily driven by contracts with BARDA and other U.S. governmental authorities.
- Gross profit: $13.274 million, showing an improvement from $7.880 million in the prior year, indicating enhanced efficiency in managing cost of revenue.
- Operating loss: $(6.582) million, a reduction from the previous year’s operating loss of $(12.984) million, suggesting improved operational efficiency and cost management.
- Net loss: $(15.315) million, compared to a net loss of $(20.854) million in the previous year, reflecting a decrease in total other expenses and improved gross profit.
- Net loss per share of common stock: $(0.85), compared to $(1.48) in the prior year, indicating a reduction in net loss…
